INTRODUCTION {#sec1-1}
============

Human beings are often exposed to free radicals which are generated from normal metabolic processes in the body. Free radicals are not always harmful; however, high level of free radicals may disturb the normal cellular mechanism by inducing oxidative damage to DNA, protein and lipids which ultimately result in chromosomal instability and mutation([@ref1][@ref2]). Moreover, overproduction of free radicals may reduce the potency of the biological defence system to detoxify these radicals which result in oxidative stress. The oxidative stress might play a role in the risk of development of several metabolic diseases like cancer, cardiovascular diseases, diabetes, obesity, neurodegenerative and aging-related disorders([@ref3][@ref4]).

Antioxidant mechanism delays or prevents free radicals formation and thereby suppresses the life-threatening diseases. Besides, it can prevent cancer progression by maintaining normal cell cycle regulation, inhibiting cell proliferation and inducing apoptosis([@ref5][@ref6]). Numerous plants and their active compounds are reported to possess the antioxidant activity which controls many disease conditions. Therefore, natural antioxidant compounds have been investigated for various types of treatment modalities including cancer([@ref7][@ref8]). In this context, we have selected the traditional Indian medicinal plant *Tephrosia purpurea* for our study. *T. purpurea* belongs to Fabaceae family, and it is distributed throughout India, popularly known as "Sharpunkha" in Sanskrit and "Wild Indigo" in English([@ref9]). In Ayurvedic medication, different parts of this plant are used to treat various diseases like asthma, diarrhoea, jaundice, rheumatism and kidney disorders([@ref10]).

*T. purpurea* has also been reported to possess many pharmacological properties like anticancer, anti-inflammatory, anti-diabetic, wound healing, hepatoprotective, antiulcer, antimalarial, antimicrobial and antioxidant activities([@ref11][@ref12][@ref13][@ref14][@ref15][@ref16][@ref17]). Despite the existence of few studies, there is no adequate knowledge about the antioxidant and cytotoxic properties of individual major parts of *T. purpurea*. Therefore, in the present study, we aimed to evaluate and compare the *in vitro* antioxidant and cytotoxic properties of methanolic extracts of *T. purpurea* leaves, root, stem and seed. We have also estimated the total phenolic and flavonoid content of these extracts by using standard methods.

MATERIALS AND METHODS {#sec1-2}
=====================

 {#sec2-1}

### Plant collection and extraction {#sec3-1}

*T. purpurea* was collected at flowering stage from JIPMER Campus, Pondicherry, India. The plant was authenticated and deposited in Tamil Nadu Agricultural University, Coimbatore, Tamil Nadu, India with voucher No. BSI/SRC/5/23/2012-13/Tech. 368. Sequentially the collected plant was cleaned, washed and air-dried. Then, 100 g of different parts of *T. purpurea* such as leaves, root, stem and seed were extracted separately with methanol using soxhlet apparatus and the concentrated extracts were stored at 4 °C until further use. All the chemicals used were of molecular and analytical grades.

### 1,1-diphenyl-2-picrylhydrazyl radical scavenging assay {#sec3-2}

1,1-diphenyl-2-picrylhydrazyl (DPPH) assay was used to study the ability of *T. purpurea* extracts to trap free radicals using previously described method with slight modifications([@ref18]). Different concentrations (50 to 500 μg/mL) of 50 μL of plant extracts was mixed with 200 μL of 0.1 mM DPPH and incubated at room temperature for 30 min in dark and the absorbance was measured at 517 nm. Ascorbic acid was used as a positive control. Conclusively, the free radical scavenging activity of extracts was calculated using the formula:

DPPH scavenging effect (%) = (control -- test / control) × 100. (1)

where, control is absorbance of vehicle at 517 nm, test is absorbance of extract at 517 nm. The concentration of plant extract required to scavenge 50% of DPPH free radicals termed as IC~50~ value.

### Ferric reducing antioxidant power {#sec3-3}

The ferric reducing antioxidant power (FRAP) assay was performed to measure the ferric tripyridyltriazine to ferrous tripyridyltriazine (Fe^2+^ -TPTZ) iron reduction by extracts according to a method suggested by Benzie and Strain([@ref19]). The FRAP was expressed as micromoles of ferrous equivalents, Fe(II) per mg of *T. purpurea* extracts (μmol Fe(II)/mg).

### The reducing power assay {#sec3-4}

Reducing power of an extract correlated with antioxidant activity, is determined by the ability to reduce Fe^3+^ to the Fe^2+^ and was described by Yen and Chen([@ref20]). The reducing power of *T. purpurea* extracts was expressed as μg/mg of quercetin equivalent (QE/mg).

### Anti-hemolytic assay {#sec3-5}

The antihemolytic activity of *T. purpurea* extracts was analysed using a previously reported method with some modifications([@ref21]). The red blood cells (RBC) were resuspended in phosphate-buffered saline (PBS) (20% cell suspension) and oxidative hemolysis was induced by addition of 2,2'-azo-bis(2-amidinopropane) hydrochloride (AAPH) which is a peroxyl radicals initiator. RBC suspension (0.5 mL) was mixed with 0.5 mL of 100 μg/mL of *T. purpurea* extracts in PBS along with 250 μL AAPH (400 mM). Further, the solution was incubated at 37^°^ C for 1 h in a water bath, followed by centrifugation at 2500 rpm for 15 min. The supernatant was collected and the absorbance was measured at 540 nm. Gallic acid was used as a positive control and AAPH without plant extracts or positive control was expressed as 100% hemolysis. The percentage of hemolytic inhibition was calculated using the following equation:

Hemolytic inhibition (%) = (control -- test/ control) × 100 (2)

where, control is the absorbance of control and test is absorbance of test (extracts or positive control).

### Cell viability assay {#sec3-6}

The cytotoxic property of *T. purpurea* extracts was assessed on SW620 colorectal cancer cells and these cells were obtained from National Center for Cell Science, Pune, India. Cancer cells were treated with 20--200 μg/mL of leaves extract and 100--1000 μg/mL of root, stem and seed extracts. 3-(4, 5-dimethylthiazolyl)-2,5 -- diphenyl -- tetrazolium bromide (MTT) colorimetric assay was used to study the cytotoxicity of the extracts (22).

### Determination of total phenolic content {#sec3-7}

Total phenolic content (TPC) of extracts was determined by Folin Ciocalteu\'s method([@ref23]). Gallic acid (20 -- 100 μg/mL) was used as a standard to plot the curve and the *T. purpurea* extracts were expressed as μg/mg of gallic acid equivalent (GAE/mg).

### Determination of total flavonoid content {#sec3-8}

The presence of total flavonoid content (TFC) in *T. purpurea* extracts was measured using aluminium chloride method, as stated by Zou, *et al*.([@ref24]). The total flavonoid content of each extract was expressed as μg/mg of quercetin equivalent (QE/mg), calculations were performed based on the calibration curve obtained from quercetin.

### Statistical analysis {#sec3-9}

Numerical data obtained from the three independent experiments were expressed as mean ± standard deviation (SD). Statistically significant differences among the four groups were analyzed using one-way analysis of variance (ANOVA) followed by Bonferroni multiple comparisons test using GraphPad (Version 3.06). A P-value \< 0.05 was considered statistically significant.

RESULTS {#sec1-3}
=======

 {#sec2-2}

### 1,1-diphenyl-2-picrylhydrazyl radical scavenging assay {#sec3-10}

The DPPH free radical scavenging (IC~50~) activity of *T. purpurea* extracts is shown in [Table 1](#T1){ref-type="table"}. The leaves extract significantly (*P* \< 0.05) quenched the DPPH free radicals at a concentration of 186.3 ± 14.0 μg/mL as compared to other extracts which had antiradical activity at the concentrations of 276.7 ± 27.5 μg/mL (root), 269.6 ± 24.5 μg/mL (stem) and 341.6 ± 36.8 μg/mL (seed). Ascorbic acid as the positive control showed the IC~50~ value at a concentration of 9.6 μg/mL.

###### 

Antioxidant activity of *Tephrosia purpura* extracts.
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### Ferric reducing activity {#sec3-11}

The leaves extract showed significantly higher ferric reducing activity (754.2 ± 50.9 μmol Fe(II)/mg) followed by the stem (484.2 ± 32.3 μmol Fe(II)/mg), seed (477.6 ± 21.4 μmol Fe(II)/mg) and root (239.5 ± 13.5 μmol Fe(II)/mg) ([Table 1](#T1){ref-type="table"}).

### Reducing power assay {#sec3-12}

The reducing power of *T. purpurea* extracts decreased as follows: Leaves (65.7 ± 4.2 μg QE/mg) \> stem (48.1 ± 5.6 μg QE/mg) \> seed (43.2 ± 3.3 μg QE/mg) \> root (28.3 ± 3.0 μg QE/mg) ([Table 1](#T1){ref-type="table"}).

### Antihemolytic activity {#sec3-13}

All four extracts showed effective antihemolytic activity on human erythrocytes against AAPH ([Table 1](#T1){ref-type="table"}). Both extracts and positive control (gallic acid: 93 ± 2) showed more than 90% of antihemolytic activity. Statistically significant difference was not observed between the four groups.

### Cytotoxicity on colorectal cancer cells {#sec3-14}

The leaves extract showed potent (p \< 0.05) cytotoxic effect against SW620 colorectal cancer cells at a concentration (IC~50~) of 95.73 ± 9.6 μg/mL. All other extracts showed the IC~50~ values \> 300 μg/mL for example, 382.33 ± 18.78 μg/mL (root), 324.80 ± 21.20 μg/mL (stem) and 303.97 ± 24.31 μg/mL (seed) ([Table 2](#T2){ref-type="table"}; [Fig. 1](#F1){ref-type="fig"}).

###### 

Cytotoxic activity, phenolic and flavonoid content of *Tephrosia purpurea* extracts.
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![The cytotoxic effect of (A) leaves, (B) root, (C) stem and (D) seed extracts of *Tephrosia purpurea* on SW620 colorectal cancer cells after exposure for 24 h. Percentage of inhibition of cancer cell proliferation was determined by MTT assay. Values are expressed as mean ± SD of three independent experiments (n = 3).](RPS-12-31-g003){#F1}

The concentration of *T. purpurea* extract required to inhibit 50% of the SW620 cancer cell growth was termed as IC~50~ value.

### Total phenolic and flavonoid content {#sec3-15}

Total phenolic and flavonoid content in four methanolic extracts of *T. purpurea* are given in [Table 2](#T2){ref-type="table"}. The TPC varies from 46.8 ± 4.0 μg GAE/mg to 90.5 ± 6.7 μg GAE/mg of the different parts of the plant. Also it was higher in the leaves extract.

The leaves and the seed extracts had the maximum amount of TFC (21.8 ± 5.4 μg QE/mg and 21.4 ± 4.2 μg QE/mg, respectively), followed by root (14.3 ± 2.9 μg QE/mg) and stem extracts (12.9 ± 3.2 μg QE/mg). However, the significant difference was not found between the studied groups ([Table 2](#T2){ref-type="table"}).

DISCUSSION {#sec1-4}
==========

The present study evaluated and compared the antioxidant and cytotoxic properties of methanolic extracts of four parts of *T. purpurea* such as leaves, root, stem and seed and also estimated their total phenolic and flavonoid content. The leaves extract showed more antioxidant and cytotoxic activities when compared to other parts.

To determine the antioxidant potential of *T. purpurea* extracts, DPPH, FRAP, reducing power assay and anti-hemolytic assay were carried out. These assays, in general, were used as *in vitro* methods to evaluate the antioxidant activity of plant extracts and compounds. The antioxidant activity indicates the capacity to quench more reactive oxygen species (ROS) leading to decreased oxidative stress. It is a well-known fact that the medicinal plants are important sources of natural antioxidants. The leaves of *T. purpurea* are rich in phenolic and flavonoid content and this could be the reason for the higher antioxidant activity. DPPH assay evaluated the potential of test compounds to quench DPPH radicals via hydrogen donating ability. The antioxidant agents convert DPPH into a stable diamagnetic molecule, 1-1diphenyl-2-picryl hydrazine by transferring electron or hydrogen. The colour change from purple to yellow indicates the increasing radical scavenging activity of the test compound([@ref25]). The DPPH free radical scavenging activity of four different parts was evaluated and compared. The leaves extract showed higher activity ([Table 1](#T1){ref-type="table"}). The DPPH radical scavenging activity of root extract is in agreement with similar results reported by a previous study by Nile, *et al*.([@ref26]). Both FRAP and reducing power assay are based on the reduction of Fe^3+^ complex to Fe^2+^ form. The reducing power of extracts was directly correlated with the antioxidant activity. In both the assays, leaves extract exhibited the highest antioxidant activity by reducing ferric iron to ferrous form. Previous studies also observed the leaves and root extract of *T. purpurea* possessed potent antioxidant activity([@ref17][@ref27]).

The oxidative stress is known to induce erythrocyte membrane lysis. The antioxidant compounds from plants are believed to inhibit RBC membrane lysis by decreasing lipid peroxidation([@ref28][@ref29]). In our study, all four extracts showed relatively similar antihemolytic activity against AAPH. This finding suggests the protective role of *T. purpurea* extracts towards RBCs by preventing the free radical-induced hemolysis. Also, it indicates nil or less toxicity to blood cells while it strongly protects the RBC cells from AAPH induced toxicity. Earlier this plant was used as a blood purifier and the reason for the same could be its protective role on RBC cells against hemolysis. A similar report where *Thymus satureioides* extract exhibited protective activity against AAPH induced hemolysis due to the presence of antioxidants([@ref30][@ref31]).

The main obstacle to current anticancer therapy is chemotherapy-induced toxicity. Whereas herbal medicines are considered safe as they produce minimal or no adverse effects over modern synthetic drugs([@ref32]). In the current study, the anticancer activity of extracts of *T. purpurea* on SW620 colorectal cancer cell lines was evaluated. The leaves extract exhibited high growth inhibitory activity on colorectal cancer cells at \< 100 μg/mL of IC~50~ concentration. While the remaining three extracts showed more than 300 μg/mL of IC~50~ values. Gulecha, *et al*. reported the cytotoxic activity of *T. purpurea* leaves fractions on MCF7 cell lines. Hussain, *et al*. reported the chemopreventive potential of *T. purpurea* on N-nitrosodiethylamine-induced hepatocarcino-genesis by virtue of its antioxidant property([@ref11][@ref33]). These findings are in concordance with the results of the present study where we observed that all the parts of *T. purpurea* extract (leaves, root, stem, and seed) exhibited cytotoxicity and this effect was more pronounced with leaves extract. The cytotoxic effect of the plant extracts could be attributed to the apoptotic activity. However, further molecular mechanistic studies are required to delineate the exact role of these extracts on the anticancer and apoptotic activity.

Our study demonstrated that the amount of TPC was higher in the extracts of all the parts of *T. purpurea*; however, it is significantly more in leaves and seed extracts. On the other hand, statistically significant difference was not observed in the flavonoid content among the four groups. A previous study has reported the presence of total phenolic and flavonoid content in aqueous and ethanolic extracts of *T. purpurea*([@ref17]). The study by Nile, *et al*. assayed the TPC and TFC of methanolic root extract of *T. purpurea* and the phenolic content reported in the study is in agreement with that reported in our study though the results of flavonoids in these studies did not agree([@ref26]). Flavonoids are the important major group of polyphenols, over 4000 varieties of flavonoids have been identified. These flavonoids often accumulate in the leaves due to the biosynthesis and also in other aerial parts of plant. This could be the reason for the presence of higher phenolic and flavonoid content in the leaves extract of *T. purpurea* in comparison with the other parts([@ref34]). Several previous studies have clearly proven that the polyphenolic compounds are excellent antioxidants and play a crucial role in the defence against free radicals due to hydrogen donating ability or potential to scavenge oxidizing species. Also, these phenols and flavonoids are reported to act as effective anticancer agents by inducing cell cycle arrest, apoptosis and anti-angiogenic activities([@ref35][@ref36][@ref37]). As reported in previous studies, our study also showed the degree of antioxidant and cytotoxic effects vary with the extent of phenolic and flavonoid content in *T. purpurea* extracts. However, the root extract though rich in phenolic and flavonoid content showed the least antioxidant and cytotoxic activities and we could not explain this exception. Further studies are needed to identify the active compounds responsible for the above activities.

CONCLUSION {#sec1-5}
==========

The leaves extract of *T. purpurea* has higher antioxidant and cytotoxic activities when compared to the extracts of root, stem and seed. This could be attributed to the presence of rich phenolic and flavonoid content in the leaves. It may be prudent to further explore the leaves extract for its usefulness in the oxidative stress induced disorders and cancer. Currently, we are in the process of isolating from the leaves of *T. purpurea* the active compounds which are responsible for the antioxidant and anticancer activity.
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